349 related articles for article (PubMed ID: 16113133)
1. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L
Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
[TBL] [Abstract][Full Text] [Related]
2. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
4. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
6. Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?
Kiljander T; Salomaa ER; Hietanen E; Helenius H; Liippo K; Terho EO
Respir Med; 2001 May; 95(5):387-92. PubMed ID: 11392580
[TBL] [Abstract][Full Text] [Related]
7. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
Orel R; Brecelj J; Homan M; Heuschkel R
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux.
Ferrari M; Benini L; Brotto E; Locatelli F; De Iorio F; Bonella F; Tacchella N; Corradini G; Lo Cascio V; Vantini I
Scand J Gastroenterol; 2007 Mar; 42(3):299-307. PubMed ID: 17354108
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
Levin TR; Sperling RM; McQuaid KR
Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
[TBL] [Abstract][Full Text] [Related]
10. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
Bishop J; Furman M; Thomson M
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
[TBL] [Abstract][Full Text] [Related]
12. Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.
Wong CH; Chua CJ; Liam CK; Goh KL
Aliment Pharmacol Ther; 2006 May; 23(9):1321-7. PubMed ID: 16629937
[TBL] [Abstract][Full Text] [Related]
13. Empiric therapy for gastroesophageal reflux disease.
Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and severity of symptoms in gastro-oesophageal reflux disease: a clinical review.
Velanovich V
Eur J Surg; 2000 Jul; 166(7):516-25. PubMed ID: 10965828
[TBL] [Abstract][Full Text] [Related]
15. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
[TBL] [Abstract][Full Text] [Related]
16. Asthma and overweight are associated with symptoms of gastro-oesophageal reflux.
Størdal K; Johannesdottir GB; Bentsen BS; Carlsen KC; Sandvik L
Acta Paediatr; 2006 Oct; 95(10):1197-201. PubMed ID: 16982489
[TBL] [Abstract][Full Text] [Related]
17. Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma.
Teichtahl H; Kronborg IJ; Yeomans ND; Robinson P
Aust N Z J Med; 1996 Oct; 26(5):671-6. PubMed ID: 8958363
[TBL] [Abstract][Full Text] [Related]
18. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-reflux surgery on chronic cough and asthma in patients with gastro-oesophageal reflux disease.
Ekström T; Johansson KE
Respir Med; 2000 Dec; 94(12):1166-70. PubMed ID: 11192951
[TBL] [Abstract][Full Text] [Related]
20. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
